Saudi wealth fund and Jared Kushner’s Affinity finalize $55 billion EA Sports deal
EA said its stock has ceased trading and will be delisted from the Nasdaq. Its shareholders will receive $210 in cash per share.
Ken Griffin’s Citadel posts best month in years after scooping up Situational Awareness stocks
The July gains came after Citadel acquired the bulk of the public-stock portfolio formerly held by Situational Awareness late last month.
Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge
Eli Lilly now expects 2026 revenue to come in between $85 billion and $87 billion, up from previous guidance of $82 billion to $85 billion.
Anthropic’s Mythos created fake identities to fool humans in new cyber incident
It’s the latest cybersecurity incident involving frontier models developed by Anthropic and OpenAI.
Oil prices fall on negotiations to manage ship traffic in Strait of Hormuz
Crude prices rose Wednesday after Yemen’s Houthis claimed they had struck a Saudi Arabian oil tanker in the Red Sea.
Lisa Su brushes off Musk’s Nvidia commitment as AMD stock sinks after earnings
The chip giant has been a big beneficiary of the AI boom, with stock trading 132% up so far in 2026.
Russian attack kills at least 17 in Kyiv as Ukraine hammers more Wildberries warehouses
The bombardment comes as each side ramps up air attacks on critical infrastructure and logistics hubs.
10-year Treasury yield slides a bit after weak ADP jobs data
The 10-year U.S. Treasury note yield fell on Wednesday following a weaker-than-expected jobs reading from payrolls processing firm ADP.
SpaceX stock falls 13% as AI spending surge rattles investors and massive share unlock looms
CEO Elon Musk said SpaceX would hit $1 trillion in annual revenue in 2030 versus a previous forecast of 2031 as he looked to strike an bullish tone.
Novo Nordisk CEO defends economics of Wegovy pill as lower prices weigh on sales; shares fall 5%
Wall Street isn’t convinced the Ozempic maker has a promising path back to sustainable growth as competition from Eli Lilly intensifies.
